[HTML][HTML] TDP-43 protein interactome informs about perturbed canonical pathways and may help develop personalized medicine approaches for patients with TDP-43 …

BR Helmold, KE Pauss, PH Ozdinler - Drug discovery today, 2023 - Elsevier
Highlights•• TDP-43 pathology cannot be explained only by gene mutations.•• Domain-
specific protein interaction network begin to reveal the canonical pathways.•• Location of …

[HTML][HTML] TDP-43 protein interactome informs about perturbed canonical pathways and may help develop personalized medicine approaches for patients with TDP-43 …

BR Helmold, KE Pauss, PH Ozdinler - Drug discovery today, 2023 - ncbi.nlm.nih.gov
Transactive response DNA binding protein of 43 kDa (TDP-43) pathology is a common
proteinopathy observed among a broad spectrum of patients with neurodegenerative …

TDP-43 protein interactome informs about perturbed canonical pathways and may help develop personalized medicine approaches for patients with TDP-43 …

BR Helmold, KE Pauss, PH Ozdinler - Drug Discovery Today, 2023 - europepmc.org
Transactive response DNA binding protein of 43 kDa (TDP-43) pathology is a common
proteinopathy observed among a broad spectrum of patients with neurodegenerative …

TDP-43 protein interactome informs about perturbed canonical pathways and may help develop personalized medicine approaches for patients with TDP-43 …

BR Helmold, KE Pauss, PH Ozdinler - Drug discovery today - pubmed.ncbi.nlm.nih.gov
Transactive response DNA binding protein of 43 kDa (TDP-43) pathology is a common
proteinopathy observed among a broad spectrum of patients with neurodegenerative …

TDP-43 protein interactome informs about perturbed canonical pathways and may help develop personalized medicine approaches for patients with TDP-43 …

BR Helmold, KE Pauss… - Drug Discovery …, 2023 - scholars.northwestern.edu
Transactive response DNA binding protein of 43 kDa (TDP-43) pathology is a common
proteinopathy observed among a broad spectrum of patients with neurodegenerative …

TDP-43 protein interactome informs about perturbed canonical pathways and may help develop personalized medicine approaches for patients with TDP-43 …

BR Helmold, KE Pauss, H Ozdinler - Drug Discovery Today, 2023 - europepmc.org
Transactive response DNA binding protein of 43 kDa (TDP-43) pathology is a common
proteinopathy observed among a broad spectrum of patients with neurodegenerative …